Training & Education

Training & Education

Patient-focused resources, tips from experts, and challenging clinical questions from ASH Clinical News

How I Treat In Brief: Managing Ibrutinib-Refractory Chronic Lymphocytic Leukemia

Jennifer A. Woyach, MD, associate professor at the Ohio State University Comprehensive Cancer Center, wrote about her strategy for the management of patients with...

How to Treat Anemia in a Patient Who Refuses Transfusions for Religious Reasons

This month, Neil A. Zakai, MD, discusses how to treat anemia in a patient who refuses packed red blood cells. And don't forget to check out...

From ASH Meeting on Hematologic Malignancies: Treating Patients With AML With Mutations and Minimal...

During their presentations, MHM speakers will be asking the audience how they would respond to patient cases. Audience members will vote live at the...

From ASH Meeting on Hematologic Malignancies: Treating “Problematic” Cases of Polycythemia Vera

During their presentations, MHM speakers will be asking the audience how they would respond to patient cases. Audience members will vote live at the...

From ASH Meeting on Hematologic Malignancies: Treating a Young Patient With Newly Diagnosed ALL

During their presentations, MHM speakers will be asking the audience how they would respond to patient cases. Audience members will vote live at the...

How would you treat a patient with autoimmune hepatitis, grade 4 cirrhosis, and declining...

This month, Spero Cataland, MD, discusses whether a patient with thrombocytopenia has hypersplenism, immune thrombocytopenia, or both. And don't forget to check out next month's...

How I Treat In Brief: Managing Disseminated Intravascular Coagulation

Recently, Marcel Levi, MD, and Marie Scully, MD, wrote about their strategies for the management of patients with disseminated intravascular coagulation (DIC). Below, we...

Next Steps After TKIs for Patient With Chronic-Phase CML?

This month, Michael Deininger, MD, PhD, discusses treatment for a patient with chronic-phase chronic myeloid leukemia (CML) whose BCR/ABL transcript levels are rising. And don't...

Is splenectomy a good option for a patient with hemoglobin H disease?

This month Swee Lay Thein, MD, discusses the pros and cons of splenectomy for a patient with hemoglobin H disease. And don't forget to check...

How I Treat In Brief: Managing Monoclonal Gammopathy of Undetermined Significance

This month, Ronald S. Go, MD, and S. Vincent Rajkumar, MD, discuss the management of patients with monoclonal gammopathy of undetermined significance (MGUS). This material was...
Advertisement

Current Issue

November 2018, Volume 4, Issue 13

This issue features a look at the U.S. drug pricing system, attempts to solve physician burnout, and more.